Skip to main content
Advertisement
Advertisement

TRAW

TRAW logo

Traws Pharma, Inc. Common Stock

0.56
USD
Sponsored
+0.06
+11.20%
Sep 24, 15:59 UTC -4
Closed
exchange

Pre-Market

0.49

-0.07
-12.50%

TRAW Earnings Reports

Positive Surprise Ratio

TRAW beat 27 of 37 last estimates.

73%

Next Report

Date of Next Report
Nov 11, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.20
Implied change from Q2 26 (Revenue/ EPS)
--
/
-20.00%
Implied change from Q3 25 (Revenue/ EPS)
--
/
--

Traws Pharma, Inc. Common Stock earnings per share and revenue

On Aug 14, 2026, TRAW reported earnings of -0.25 USD per share (EPS) for Q2 26, beating the estimate of -0.34 USD, resulting in a 26.94% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -5.43% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.20 USD, with revenue projected to reach -- USD, implying an decrease of -20.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, Traws Pharma, Inc. Common Stock reported EPS of -$0.25, beating estimates by 26.94%, and revenue of $0.00, 0% as expectations.
The stock price moved down -5.43%, changed from $0.57 before the earnings release to $0.54 the day after.
The next earning report is scheduled for Nov 11, 2026.
Based on 3 analysts, Traws Pharma, Inc. Common Stock is expected to report EPS of -$0.20 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement